Accelerated corneal crosslinking (CXL) procedure
Accelerated treatment improves keratoconus, BCVA with less pain at 24 months
Howard Larkin
Published: Wednesday, January 25, 2017
Accelerated transepithelial CXL was safe and effective for progressive keratoconus with a reduced rate of complications and operative and postoperative discomfort related to epithelial removalUVA 370nm was applied at 30mW/cm² with continued application of 0.25% riboflavin for three minutes, delivering a total dose of 5.4J/cm². An optical antibiotic ointment ofloxacin 0.3% and bandage were applied for one day, and antibiotic drop 1.5% levofloxacin and corticosteroid 0.1% fluorometholone applied topically for one week. No intraoperative or postoperative complications were observed, and all 21 eyes completed follow-up. At 24 months, mean BCVA improved from about 0.22 logMAR to about 0.08 (P=0.2). Kmax declined from a mean of about 59 dioptres to 55.5 (P=0.003) and average K from about 52 to 49 dioptres (P=0.02). Thinnest corneal readings also dropped significantly though central corneal thickness remained stable, as did endothelial cell density and intraocular pressure, Dr Aixinjueluo reported. “Accelerated transepithelial CXL was safe and effective for progressive keratoconus with a reduced rate of complications and operative and postoperative discomfort related to epithelial removal,” she concluded. Wei Aixinjueluo: waixinjueluo@yahoo.co.jp
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular
Long-awaited cellular therapies for corneal endothelial disease enter the clinic.
Balancing Innovation and Safety
Ensuring access to advanced cell therapies amid regulatory overhaul.
With Eyes on Its Future, ESCRS Celebrates Its Past
Winter Meeting offers opportunities to experiment with new concepts and formats.
Best of ESCRS Winter Meeting 2024
Following the New Generation
EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.
Refocus on Multifocals
Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.
Common Myths in Presbyopia Correction
Patient education key to satisfaction with refractive IOLs.
Reversible Multifocality
Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.
Managing a Cataract Surgery Refractive Miss
Weighing the pros and cons of options for intraocular intervention.
Unleashing OCT’s Full Potential
Performance of newest tool for corneal evaluation meets or beats older standard technologies.